Abstract

Review Article

COVID-19, Long COVID, and Gastrointestinal Neoplasms: Exploring the Impact of Gut Microbiota and Oncogenic Interactions

Amália Cinthia Meneses do Rêgo and Irami Araújo-Filho*

Published: 04 September, 2024 | Volume 8 - Issue 1 | Pages: 054-062

Background: The impact of COVID-19 and long-term COVID-19 on gastrointestinal neoplasms remains underexplored. The current review investigates the potential link between these conditions and the role of gut microbiota in mediating oncogenic processes. Dysbiosis, characterized by alterations in gut microbial composition, may exacerbate inflammation and immune dysregulation, contributing to cancer development.
Methods: A comprehensive literature review was conducted using databases including PubMed, Scopus, Embase, SciELO, and Web of Science. Inclusion criteria encompassed studies published between 2020 and 2024 that explored the intersection of COVID-19, long-term COVID-19, and gastrointestinal cancers. The articles were critically appraised for quality and relevance, and data were synthesized to elucidate common mechanisms and outcomes.
Results: The review identifies several mechanisms by which gut microbiota may influence cancer risk in COVID-19 patients. Persistent inflammation, oxidative stress, and immune dysfunction observed in Long COVID were associated with dysbiosis. Specific microbial metabolites, such as secondary bile and short-chain fatty acids, were implicated in promoting tumorigenesis. Comparative analysis of studies suggests that SARS-CoV-2-induced dysbiosis may heighten susceptibility to gastrointestinal cancers, particularly in patients with prolonged post-infection symptoms.
Conclusion: The findings underscore the need for further research to clarify the role of gut microbiota in cancer development among COVID-19 patients. These mechanisms could inform preventative strategies and therapeutic interventions, particularly for those experiencing COVID. The review highlights gaps in current knowledge and advocates for longitudinal studies to assess the long-term effects of COVID-19 on gastrointestinal health.

Read Full Article HTML DOI: 10.29328/journal.acst.1001045 Cite this Article Read Full Article PDF

Keywords:

COVID-19; Long COVID; Gastrointestinal neoplasms; Gut microbiota; Inflammation; Oncogenesis

References

  1. Cai J, Sun L, Gonzalez FJ. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe. 2022;30(3):289-300. Available from: https://doi.org/10.1016/j.chom.2022.02.004
  2. Sedlak JC, Yilmaz ÖH, Roper J. Metabolism and colorectal cancer. Annu Rev Pathol. 2023;18:467-492. Available from: https://doi.org/10.1146/annurev-pathmechdis-031521-041113
  3. Wong CC, Yu J. Gut microbiota in colorectal cancer development and therapy. Nat Rev Clin Oncol. 2023;20(7):429-452. Available from: https://doi.org/10.1038/s41571-023-00766-x
  4. Kim J, Lee HK. Potential role of the gut microbiome in colorectal cancer progression. Front Immunol. 2022;12:807648. Available from: https://doi.org/10.3389/fimmu.2021.807648
  5. Qu R, Zhang Y, Ma Y, Zhou X, Sun L, Jiang C, et al. Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer. Adv Sci (Weinh). 2023;10(23). Available from: https://doi.org/10.1002/advs.202205563
  6. Wang Z, Dan W, Zhang N, Fang J, Yang Y. Colorectal cancer and gut microbiota studies in China. Gut Microbes. 2023;15(1):2236364. Available from: https://doi.org/10.1080%2F19490976.2023.2236364
  7. Clay SL, Fonseca-Pereira D, Garrett WS. Colorectal cancer: the facts in the case of the microbiota. J Clin Invest. 2022;132(4). Available from: https://doi.org/10.1172/jci155101
  8. Pernigoni N, Guo C, Gallagher L, Yuan W, Colucci M, Troiani M, et al. The potential role of the microbiota in prostate cancer pathogenesis and treatment. Nat Rev Urol. 2023;20(12):706-718. Available from: https://doi.org/10.1038/s41585-023-00795-2
  9. Sun J, Xia Y. Microbiome in colonic carcinogenesis. Compr Physiol. 2023;13(3):4685-4708. Available from: https://doi.org/10.1002/cphy.c210052
  10. Eladwy RA, Vu HT, Shah R, Li CG, Chang D, Bhuyan DJ. The fight against the carcinogenic Epstein-Barr virus: gut microbiota, natural medicines, and beyond. Int J Mol Sci. 2023;24(2):1716. Available from: https://doi.org/10.3390/ijms24021716
  11. Han J, Zhang B, Zhang Y, Yin T, Cui Y, Liu J, et al. Gut microbiome: decision-makers in the microenvironment of colorectal cancer. Front Cell Infect Microbiol. 2023;13:1299977. Available from: https://doi.org/10.3389%2Ffcimb.2023.1299977
  12. Makaranka S, Scutt F, Frixou M, Wensley KE, Sharma R, Greenhowe J. The gut microbiome and melanoma: a review. Exp Dermatol. 2022;31(9):1292-1301. Available from: https://doi.org/10.1111/exd.14639
  13. Newsome R, Yang Y, Jobin C. Western diet influences on microbiome and carcinogenesis. Semin Immunol. 2023;67:101756. Available from: https://doi.org/10.1016/j.smim.2023.101756
  14. Attebury H, Daley D. The gut microbiome and pancreatic cancer development and treatment. Cancer J. 2023;29(2):49-56. Available from: https://doi.org/10.1097%2FPPO.0000000000000647
  15. Cass SH, Ajami NJ, White MG. The microbiome: The link to colorectal cancer and research opportunities. Curr Treat Options Oncol. 2022;23(5):631-644. Available from: https://doi.org/10.1007/s11864-022-00960-6
  16. Rahman MM, Islam MR, Shohag S, Ahasan MT, Sarkar N, Khan H, et al. Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies. Biomed Pharmacother. 2022;149:112898. Available from: https://doi.org/10.1016/j.biopha.2022.112898
  17. Gong Y, Huang X, Wang M, Liang X. Intratumor microbiota: a novel tumor component. J Cancer Res Clin Oncol. 2023;149(9):6675-6691. Available from: https://doi.org/10.1007/s00432-023-04576-7
  18. Yu Y, Zhong W. Interaction of microbiome and immunity in tumorigenesis and clinical treatment. Biomed Pharmacother. 2022;156:113894. Available from: https://doi.org/10.1016/j.biopha.2022.113894
  19. Wang L, Yu KC, Hou YQ, Guo M, Yao F, Chen ZX. Gut microbiome in tumorigenesis and therapy of colorectal cancer. J Cell Physiol. 2023;238(1):94-108. Available from: https://doi.org/10.1002/jcp.30917
  20. Liu Y, Lau HC, Cheng WY, Yu J. Gut microbiome in colorectal cancer: Clinical diagnosis and treatment. Genomics Proteomics Bioinformatics. 2023;21(1):84-96. Available from: https://doi.org/10.1016/j.gpb.2022.07.002
  21. Kumavath R, Pavithran H, Paul S, Anju VT, Busi S, Dyavaiah M. Effects of gut microbiome and obesity on the development, progression and prevention of cancer. Int J Oncol. 2024;64(1):4. Available from: https://doi.org/10.3892/ijo.2023.5592
  22. Liu Y, Lau HC, Yu J. Microbial metabolites in colorectal tumorigenesis and cancer therapy. Gut Microbes. 2023;15(1):2203968. Available from: https://doi.org/10.1080%2F19490976.2023.2203968
  23. Nabavi-Rad A, Yadegar A, Sadeghi A, Aghdaei HA, Zali MR, Klionsky DJ, et al. The interaction between autophagy, Helicobacter pylori, and gut microbiota in gastric carcinogenesis. Trends Microbiol. 2023;31(10):1024-1043. Available from: https://doi.org/10.1016/j.tim.2023.04.001
  24. Nakatsu G, Andreeva N, MacDonald MH, Garrett WS. Interactions between diet and gut microbiota in cancer. Nat Microbiol. 2024;9(7):1644-1654. Available from: https://doi.org/10.1038/s41564-024-01736-4
  25. Sun J. Impact of bacterial infection and intestinal microbiome on colorectal cancer development. Chin Med J (Engl). 2022;135(4):400-408. Available from: https://doi.org/10.1097%2FCM9.0000000000001979
  26. Samami E, Aleebrahim-Dehkordi E, Mohebalizadeh M, Yaribash S, Saghazadeh A, Rezaei N. Inosine, gut microbiota, and cancer immunometabolism. Am J Physiol Endocrinol Metab. 2023;324(1). Available from: https://doi.org/10.1152/ajpendo.00207.2022
  27. Zhu G, Jin L, Shen W, Zhao M, Liu N. Intratumor microbiota: occult participants in the microenvironment of multiple myeloma. Biochim Biophys Acta Rev Cancer. 2023;1878(5):188959. Available from: https://doi.org/10.1016/j.bbcan.2023.188959
  28. Sevcikova A, Mladosievicova B, Mego M, Ciernikova S. Exploring the role of the gut and intratumoral microbiomes in tumor progression and metastasis. Int J Mol Sci. 2023;24(24):17199. Available from: https://doi.org/10.3390%2Fijms242417199
  29. Cruz MS, Tintelnot J, Gagliani N. Roles of microbiota in pancreatic cancer development and treatment. Gut Microbes. 2024;16(1):2320280. Available from: https://doi.org/10.1080%2F19490976.2024.2320280
  30. Mendes I, Vale N. How can the microbiome induce carcinogenesis and modulate drug resistance in cancer therapy? Int J Mol Sci. 2023;24(14):11855. Available from: https://doi.org/10.3390/ijms241411855
  31. Qian J, Zhang X, Wei B, Tang Z, Zhang B. The correlation between gut and intra-tumor microbiota and PDAC: etiology, diagnostics and therapeutics. Biochim Biophys Acta Rev Cancer. 2023;1878(5):188943. Available from: https://doi.org/10.1016/j.bbcan.2023.188943
  32. Baas FS, Brusselaers N, Nagtegaal ID, Engstrand L, Boleij A. Navigating beyond associations: opportunities to establish causal relationships between the gut microbiome and colorectal carcinogenesis. Cell Host Microbe. 2024;32(8):1235-1247. Available from: https://doi.org/10.1016/j.chom.2024.07.008
  33. Kaźmierczak-Siedlecka K, Daca A, Roviello G, Catalano M, Połom K. Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis—what is currently known? Gastric Cancer. 2022;25(1):1-10. Available from: https://doi.org/10.1007%2Fs10120-021-01260-y
  34. Silveira MAD, Bilodeau S, Greten TF, Wang XW, Trinchieri G. The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis. Trends Cancer. 2022;8(7):583-597. Available from: https://doi.org/10.1016/j.trecan.2022.02.009
  35. Shi L, Xu Y, Feng M. Role of gut microbiome in immune regulation and immune checkpoint therapy of colorectal cancer. Dig Dis Sci. 2023;68(2):370-379. Available from: https://doi.org/10.1007/s10620-022-07689-0
  36. Doocey CM, Finn K, Murphy C, Guinane CM. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. BMC Microbiol. 2022;22(1):53. Available from: https://doi.org/10.1186/s12866-022-02465-6
  37. Zhou P, Hu Y, Wang X, Shen L, Liao X, Zhu Y, et al. Microbiome in cancer: an exploration of carcinogenesis, immune responses and immunotherapy. Front Immunol. 2022;13:877939. Available from: https://doi.org/10.3389/fimmu.2022.877939
  38. Rana D, Salave S, Perla A, Nadkarni A, Kolhe S, Jindal AB, et al. Bugs as drugs: understanding the linkage between gut microbiota and cancer treatment. Curr Drug Targets. 2022;23(9):869-888. Available from: https://doi.org/10.2174/1389450123666220309101345
  39. Feizi H, Rezaee MA, Ghotaslou R, Sadrkabir M, Jadidi-Niaragh F, Gholizadeh P, et al. Gut microbiota and colorectal cancer risk factors. Curr Pharm Biotechnol. 2023;24(8):1018-1034. Available from: https://doi.org/10.2174/1389201023666221005103340
  40. Liu Q, Yang Y, Pan M, Yang F, Yu Y, Qian Z. Role of the gut microbiota in tumorigenesis and treatment. Theranostics. 2024;14(6):2304-2328. Available from: https://doi.org/10.7150%2Fthno.91700
  41. Ali A, Ara A, Kashyap MK. Gut microbiota: role and association with tumorigenesis in different malignancies. Mol Biol Rep. 2022;49(8):8087-8107. Available from: https://doi.org/10.1007/s11033-022-07357-6
  42. Kashyap S, Pal S, Chandan G, Saini V, Chakrabarti S, Saini NK, et al. Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers. Semin Cancer Biol. 2022;86(Pt 3):643-651. Available from: https://doi.org/10.1016/j.semcancer.2021.04.020
  43. Pandey P, Khan F. Gut microbiome in cancer immunotherapy: current trends, translational challenges and future possibilities. Biochim Biophys Acta Gen Subj. 2023;1867(9):130401. Available from: https://doi.org/10.1016/j.bbagen.2023.130401
  44. Ait-Zenati F, Djoudi F, Mehelleb D, Madaoui M. Involvement of the human microbiome in frequent cancers, current knowledge and carcinogenesis mechanisms. Bull Cancer. 2023;110(7-8):776-789. Available from: https://doi.org/10.1016/j.bulcan.2023.01.022
  45. Lee SY, Lee DY, Kang JH, Kim JH, Jeong JW, Kim HW, et al. Relationship between gut microbiota and colorectal cancer: probiotics as a potential strategy for prevention. Food Res Int. 2022;156:111327. Available from: https://doi.org/10.1016/j.foodres.2022.111327
  46. Lozenov S, Krastev B, Nikolaev G, Peshevska-Sekulovska M, Peruhova M, Velikova T. Gut microbiome composition and its metabolites are a key regulating factor for malignant transformation, metastasis and antitumor immunity. Int J Mol Sci. 2023;24(6):5978. Available from: https://doi.org/10.3390/ijms24065978
  47. Yang Q, Zhang J, Zhu Y. Potential roles of the gut microbiota in pancreatic carcinogenesis and therapeutics. Front Cell Infect Microbiol. 2022;12:872019. Available from: https://doi.org/10.3389%2Ffcimb.2022.872019
  48. Matsushita M, Fujita K, Hatano K, De Velasco MA, Uemura H, Nonomura N. Connecting the dots between the gut-IGF-1-prostate axis: a role of IGF-1 in prostate carcinogenesis. Front Endocrinol (Lausanne). 2022;13:852382. Available from: https://doi.org/10.3389%2Ffendo.2022.852382
  49. Jaye K, Li CG, Chang D, Bhuyan DJ. The role of key gut microbial metabolites in the development and treatment of cancer. Gut Microbes. 2022;14(1):2038865. Available from: https://doi.org/10.1080/19490976.2022.2038865
  50. Wang S, Xu B, Zhang Y, Chen G, Zhao P, Gao Q, Yuan L. The role of intestinal flora on tumorigenesis, progression, and the efficacy of PD-1/PD-L1 antibodies in colorectal cancer. Cancer Biol Med. 2023;21(1):65-82. Available from: https://doi.org/10.20892%2Fj.issn.2095-3941.2023.0376
  51. Wu H, Ma W, Wang Y, Wang Y, Sun X, Zheng Q. Gut microbiome-metabolites axis: a friend or foe to colorectal cancer progression. Biomed Pharmacother. 2024;173:116410. Available from: https://doi.org/10.1016/j.biopha.2024.116410
  52. Fakharian F, Asgari B, Nabavi-Rad A, Sadeghi A, Soleimani N, Yadegar A, et al. The interplay between Helicobacter pylori and the gut microbiota: an emerging driver influencing the immune system homeostasis and gastric carcinogenesis. Front Cell Infect Microbiol. 2022;12:953718. Available from: https://doi.org/10.3389/fcimb.2022.953718
  53. Grochowska M, Perlejewski K, Laskus T, Radkowski M. The role of gut microbiota in gastrointestinal tract cancers. Arch Immunol Ther Exp (Warsz). 2022;70(1):7. Available from: https://doi.org/10.1007%2Fs00005-021-00641-6
  54. Nouri R, Hasani A, Asgharzadeh M, Sefidan FY, Hemmati F, Rezaee MA. Roles of gut microbiota in colorectal carcinogenesis providing a perspective for early diagnosis and treatment. Curr Pharm Biotechnol. 2022;23(13):1569-1580. Available from: https://doi.org/10.2174/1389201023666220307112413
  55. Sadrekarimi H, Gardanova ZR, Bakhshesh M, Ebrahimzadeh F, Yaseri AF, Thangavelu L, et al. Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora. J Transl Med. 2022;20(1):301. Available from: https://doi.org/10.1186/s12967-022-03492-7
  56. Pan S, Guo Y, Hong F, Xu P, Zhai Y. Therapeutic potential of melatonin in colorectal cancer: focus on lipid metabolism and gut microbiota. Biochim Biophys Acta Mol Basis Dis. 2022;1868(1):166281. Available from: https://doi.org/10.1016/j.bbadis.2021.166281
  57. Chattopadhyay I, Gundamaraju R, Jha NK, Gupta PK, Dey A, Mandal CC, et al. Interplay between dysbiosis of gut microbiome, lipid metabolism, and tumorigenesis: can gut dysbiosis stand as a prognostic marker in cancer? Dis Markers. 2022;2022:2941248. Available from: https://doi.org/10.1155%2F2022%2F2941248
  58. Bennedsen ALB, Furbo S, Bjarnsholt T, Raskov H, Gögenur I, Kvich L. The gut microbiota can orchestrate the signaling pathways in colorectal cancer. APMIS. 2022;130(3):121-139. Available from: https://doi.org/10.1111/apm.13206
  59. Acharya S, Thirunavukkarasu C. Gut microbiome and cancer: from cancer development to therapeutics with a special focus on hepatocellular carcinoma. Front Biosci (Landmark Ed). 2024;29(2):67. Available from: https://doi.org/10.31083/j.fbl2902067
  60. Huang C, Mei S, Zhang X, Tian X. Inflammatory milieu related to dysbiotic gut microbiota promotes tumorigenesis of hepatocellular carcinoma. J Clin Gastroenterol. 2023;57(8):782-788. Available from: https://doi.org/10.1097/mcg.0000000000001883
  61. Li L, Huang X, Chen H. Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics. Gut Microbes. 2024;16(1):2328868. Available from: https://doi.org/10.1080%2F19490976.2024.2328868
  62. Zhang Z, Bahaji Azami NL, Liu N, Sun M. Research progress of intestinal microecology in the pathogenesis of colorectal adenoma and carcinogenesis. Technol Cancer Res Treat. 2023;22:15330338221135938. Available from: https://doi.org/10.1177%2F15330338221135938
  63. Pandey M, Bhattacharyya J. Gut microbiota and epigenetics in colorectal cancer: implications for carcinogenesis and therapeutic intervention. Epigenomics. 2024;16(6):403-418. Available from: https://doi.org/10.2217/epi-2023-0382
  64. Chung IY, Kim J, Koh A. The microbiome matters: its impact on cancer development and therapeutic responses. J Microbiol. 2024;62(3):137-152. Available from: https://link.springer.com/article/10.1007/s12275-024-00110-7
  65. Xing J, Fang Y, Zhang W, Zhang H, Tang D, Wang D. Bacterial driver-passenger model in biofilms: a new mechanism in the development of colorectal cancer. Clin Transl Oncol. 2022;24(5):784-795. Available from: https://doi.org/10.1007/s12094-021-02738-y
  66. Pallozzi M, De Gaetano V, Di Tommaso N, Cerrito L, Santopaolo F, Stella L, et al. Role of gut microbial metabolites in the pathogenesis of primary liver cancers. Nutrients. 2024;16(14):2372. Available from: https://doi.org/10.3390/nu16142372
  67. Liu R, Wang J, Liu Y, Gao Y, Yang R. Regulation of gut microbiota on immune cell ferroptosis: a novel insight for immunotherapy against tumor. Cancer Lett. 2024;598:217115. Available from: https://doi.org/10.1016/j.canlet.2024.217115
  68. Zhang Y, Tang N, Zhou H, Zhu Y. The role of microbial metabolites in endocrine tumorigenesis: from the mechanistic insights to potential therapeutic biomarkers. Biomed Pharmacother. 2024;172:116218. Available from: https://doi.org/10.1016/j.biopha.2024.116218
  69. Makaranka S, Scutt F, Frixou M, Wensley KE, Sharma R, Greenhowe J. The gut microbiome and melanoma: a review. Exp Dermatol. 2022;31(9):1292-1301. Available from: https://doi.org/10.1111/exd.14639
  70. Newsome R, Yang Y, Jobin C. Western diet influences on microbiome and carcinogenesis. Semin Immunol. 2023;67:101756. Available from: https://doi.org/10.1016/j.smim.2023.101756
  71. Attebury H, Daley D. The gut microbiome and pancreatic cancer development and treatment. Cancer J. 2023;29(2):49-56. Available from: https://doi.org/10.1097/ppo.0000000000000647 

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?